Literature DB >> 21859851

Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).

Chiung-Yu Hung1, Angel Gonzalez, Marcel Wüthrich, Bruce S Klein, Garry T Cole.   

Abstract

We have previously reported that C57BL/6 mice vaccinated with a live, attenuated mutant of Coccidioides posadasii, referred to as the ΔT vaccine, are fully protected against pulmonary coccidioidomycosis. This model was used here to explore the nature of vaccine immunity during the initial 2-week period after intranasal challenge. Elevated neutrophil and eosinophil infiltration into the lungs of nonvaccinated mice contrasted with markedly reduced recruitment of these cells in vaccinated animals. The numbers of lung-infiltrated macrophages and dendritic cells showed a progressive increase in vaccinated mice and corresponded with reduction of the lung infection. Concentrations of selected inflammatory cytokines and chemokines were initially higher in lung homogenates of vaccinated mice but then generally decreased at 14 days postchallenge in correlation with containment of the organism and apparent dampening of the inflammation of host tissue. Profiles of cytokines detected in lung homogenates of ΔT-vaccinated mice were indicative of a mixed T helper 1 (Th1)-, Th2-, and Th17-type immune response, a conclusion which was supported by detection of lung infiltration of activated T cells with the respective CD4(+) gamma interferon (IFN-γ)(+), CD4(+) interleukin-5 (IL-5)(+), and CD4(+) IL-17A(+) phenotypes. While Th1 and Th2 immunity was separately dispensed of by genetic manipulation without loss of ΔT vaccine-mediated protection, loss of functional Th17 cells resulted in increased susceptibility to infection in immunized mice. Characterization of the early events of protective immunity to Coccidioides infection in vaccinated mice contributes to the identification of surrogates of immune defense and provides potential insights into the design of immunotherapeutic protocols for treatment of coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859851      PMCID: PMC3257932          DOI: 10.1128/IAI.05726-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice.

Authors:  Angel Gonzalez; Chiung-Yu Hung; Garry T Cole
Journal:  Microb Pathog       Date:  2011-04-14       Impact factor: 3.738

2.  Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-alpha or interferon-gamma through nuclear factor-kappaB or STAT-1 in airway epithelial cells.

Authors:  Tetsuya Homma; Satoshi Matsukura; Takashi Hirose; Tsukasa Ohnishi; Teruaki Kimura; Masatsugu Kurokawa; Koushi Ieki; Miho Odaka; Shintaro Suzuki; Shin Watanabe; Masayuki Sato; Mio Kawaguchi; Robert P Schleimer; Mitsuru Adachi
Journal:  Int Arch Allergy Immunol       Date:  2010-06-04       Impact factor: 2.749

3.  Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.

Authors:  C R Zimmermann; S M Johnson; G W Martens; A G White; B L Zimmer; D Pappagianis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection.

Authors:  Chiung-Yu Hung; Kalpathi R Seshan; Jieh-Juen Yu; Ruth Schaller; Jianmin Xue; Venkatesha Basrur; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation.

Authors:  J O Richards; N M Ampel; J N Galgiani; D F Lake
Journal:  J Infect Dis       Date:  2001-09-19       Impact factor: 5.226

6.  Lysophosphatidic acid inhibits CC chemokine ligand 5/RANTES production by blocking IRF-1-mediated gene transcription in human bronchial epithelial cells.

Authors:  Shinichi Matsuzaki; Tamotsu Ishizuka; Takeshi Hisada; Haruka Aoki; Mayumi Komachi; Isao Ichimonji; Mitsuyoshi Utsugi; Akihiro Ono; Yasuhiko Koga; Kunio Dobashi; Hitoshi Kurose; Hideaki Tomura; Masatomo Mori; Fumikazu Okajima
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

7.  Tissue eosinophilia in human coccidioidomycosis.

Authors:  R M Echols; D L Palmer; G W Long
Journal:  Rev Infect Dis       Date:  1982 May-Jun

8.  Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.

Authors:  Rekha R Rapaka; David M Ricks; John F Alcorn; Kong Chen; Shabaana A Khader; Mingquan Zheng; Scott Plevy; Eva Bengtén; Jay K Kolls
Journal:  J Exp Med       Date:  2010-12-13       Impact factor: 14.307

9.  Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.

Authors:  Marcel Wüthrich; Benjamin Gern; Chiung Yu Hung; Karen Ersland; Nicole Rocco; John Pick-Jacobs; Kevin Galles; Hanna Filutowicz; Thomas Warner; Michael Evans; Garry Cole; Bruce Klein
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 19.456

10.  Estimating severe coccidioidomycosis in California.

Authors:  Valerie J Flaherman; Richard Hector; George W Rutherford
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more
  44 in total

1.  CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against Coccidioides posadasii Infection.

Authors:  Althea Campuzano; Hao Zhang; Gary R Ostroff; Lucas Dos Santos Dias; Marcel Wüthrich; Bruce S Klein; Jieh-Juen Yu; Humberto H Lara; Jose L Lopez-Ribot; Chiung-Yu Hung
Journal:  J Immunol       Date:  2020-05-01       Impact factor: 5.422

2.  Inflammatory and Anti-inflammatory Responses Co-exist Inside Lung Granuloma of Fatal Cases of Coccidioidomycosis: A Pilot Report.

Authors:  Heidi G Rodriguez-Ramirez; Adolfo Soto-Dominguez; Gloria M González; Oralia Barboza-Quintana; Mario C Salinas-Carmona; Luis A Ceceñas-Falcon; Roberto Montes-de-Oca-Luna; Alma Y Arce-Mendoza; Adrian G Rosas-Taraco
Journal:  Mycopathologia       Date:  2018-05-07       Impact factor: 2.574

3.  Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection.

Authors:  Marcel Wüthrich; Vanessa LeBert; Kevin Galles; Jane Hu-Li; Shlomo Z Ben-Sasson; William E Paul; Bruce S Klein
Journal:  J Infect Dis       Date:  2013-06-20       Impact factor: 5.226

Review 4.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

Review 5.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

6.  Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.

Authors:  George S Deepe; William R Buesing; Gary R Ostroff; Ambily Abraham; Charles A Specht; Haibin Huang; Stuart M Levitz
Journal:  Vaccine       Date:  2018-05-02       Impact factor: 3.641

7.  Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

Authors:  Lisa F Shubitz; Daniel A Powell; Hien T Trinh; M Lourdes Lewis; Marc J Orbach; Jeffrey A Frelinger; John N Galgiani
Journal:  Vaccine       Date:  2018-04-30       Impact factor: 3.641

8.  Extracellular ammonia at sites of pulmonary infection with Coccidioides posadasii contributes to severity of the respiratory disease.

Authors:  Hua Zhang Wise; Chiung-Yu Hung; Emily Whiston; John W Taylor; Garry T Cole
Journal:  Microb Pathog       Date:  2013-04-10       Impact factor: 3.738

9.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

10.  Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.

Authors:  Brady J Hurtgen; Natalia Castro-Lopez; Maria Del Pilar Jiménez-Alzate; Garry T Cole; Chiung-Yu Hung
Journal:  Vaccine       Date:  2016-09-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.